Very high-risk familial hypercholesterolaemia patients in real life: The remaining gap in achieving the current LDL-C targets despite the use of PCSK9 inhibitors
Rallidis, Loukianos S., Liberopoulos, Evangelos N., Vlachopoulos, Charalambos, Skoumas, Ioannis, Kolovou, Genovefa, Anastasiou, Georgia, Dima, Ioanna, Tousoulis, Dimitrios, Iliodromitis, EfstathiosJournal:
Atherosclerosis
DOI:
10.1016/j.atherosclerosis.2020.07.018
Date:
July, 2020
File:
PDF, 375 KB
2020